Omnia Wellness (OMWS) 10-K/A 28 Mar 22 2021 FY Annual report (amended) Financial data

Cover

Cover - USD ($)	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2021	Jul. 28, 2021
Cover [Abstract]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	The Company is filing this Amendment No. 1 on Form 10-K/A (this “Form 10-K/A” or “Amended Filing”) to amend its original Form 10-K for the year ended March 31, 2021, originally filed with the Securities and Exchange Commission (the “SEC”) on July 30, 2021 (the “Original Filing”), to restate its audited consolidated financial statements and related footnote disclosures for the year ended March 31, 2021 to (a) retroactively report an April 6, 2021 15-1 forward stock split, (b) delete the incorrect leases of inventory revenue disclosure statement for the period covered in the Original Filing and (c) recalculate the weighted average earnings per share.
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2021
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--03-31
Entity File Number	000-211986
Entity Registrant Name	OMNIA WELLNESS INC.
Entity Central Index Key	0001676852
Entity Tax Identification Number	98-1291924
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	999 18th Street
Entity Address, Address Line Two	Suite 3000
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	(303)
Local Phone Number	325-3738
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float		$ 9,691,463.40
Entity Common Stock, Shares Outstanding			224,227,107
Documents incorporated by reference	None

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Current assets
Cash	$ 28,761
Accounts Receivable	38,341
Due from related parties	163,200
Advances on Inventory	16,000	0
Total current assets	246,302
Non-current assets
Fixed assets, net	314,377
Intangible assets, net	1,600,975
Total non-current assets	1,915,352
Total Assets	2,161,654
Current liabilities:
Accounts payable and accrued expenses	103,205
Accounts payable, related party	1,500	0
Deposit Liability	21,764
Accrued interest	427,910	14,467
Warranty liability	25,667
Nonconvertible notes, related party	834,653	12,000
Nonconvertible notes, non relatd	1,745,000
Convertible notes, related party	29,970	6,546
Convertible notes, non related	1,107,143
Total current liabilities	4,296,812	33,013
Non-current liabilities:
PPP Loan	588,891
Nonconvertible notes, related party	509,972
Nonconvertible notes, non related	174,620
Total non-current liabilities	1,273,483
Total Liabilities	5,570,294	33,013
Stockholders’ deficit:
Common stock, par value $0.001; Authorized – 1,500,000,000; Issued and outstanding 224,227,107 (March 31, 2020- 1,500,000,000 authorized and 264,384,488 issued and outstanding)	14,900	55,058
Additional paid-in capital	2,065,923	(10,224)
Accumulated deficit	(5,489,464)	(77,847)
Total stockholders’ deficit	(3,408,640)	(33,013)
Total Liabilities and Stockholders’ Deficit	$ 2,161,654

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2021	Mar. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	150,000,000	150,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	224,227,107	264,384,488
Common stock, shares outstanding	224,227,107	264,384,488

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Total Revenues	$ 218,874
Revenue
Cost of goods sold, related party	120,253
Installation fees
Total cost of goods sold	120,253
Gross Profit	98,621
Operating expenses
Warranty expense	13,399
Depreciation and amortization	272,779
Legal and professional fees	177,589
Payroll expense	240,395
Selling and marketing expense	52,804
Selling and marketing expense, related party	356,261
Consulting expense	25,985
Consulting expense, related party	244,186
License royalties	33,771
General and administrative	304,992	33,680
Impairment Expense
Total operating expenses	1,722,161	33,680
Other income (expense)
Interest income
Interest expense	(611,536)
Total other income (expense)	(611,536)
Net loss	$ (2,235,075)	$ (33,680)
Net loss per common share - Basic and Diluted	$ (0.01)	$ 0
Weighted average number of common shares outstanding - Basic and Diluted	191,762,740	264,384,488
Sales, Net [Member]
Total Revenues	$ 218,124
Freight and Delivery [Member]
Total Revenues	$ 750

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 31, 2019		$ 55,058	$ (24,923)	$ (44,167)	$ (14,032)
Beginning balance, shares at Mar. 31, 2019		264,384,488
Forgiveness of Debt to Former Shareholder			14,699		14,699
Change in shares issued
Change in shares issued, shares
Conversion of Debt
Reverse Merger Consolidation Adjustment
Net loss				(33,680)	(33,680)
Ending balance, value at Mar. 31, 2020		$ 55,058	(10,224)	(77,847)	(33,013)
Ending balance, shares at Mar. 31, 2020		264,384,488
Change in shares issued		$ (40,158)			(40,158)
Change in shares issued, shares		(40,157,381)
Conversion of Debt			2,076,147		2,076,147
Reverse Merger Consolidation Adjustment				(3,176,541)	(3,176,541)
Net loss				(2,235,075)	(2,235,075)
Ending balance, value at Mar. 31, 2021		$ 14,900	$ 2,065,923	$ (5,489,463)	$ (3,408,640)
Ending balance, shares at Mar. 31, 2021		224,227,107

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,235,075)	$ (33,680)
Depreciation and amortization expense	272,779	215
Changes in operating assets and liabilities:
Accounts receivables, net	(38,341)
Due from related parties	(163,200)
Advance payments on purchase of inventory, related party	(16,000)
Accounts payable and accrued expenses	152,136	(791)
Interest payable	413,443	11,467
Net Cash Used In Operating Activities	(1,614,258)	(22,789)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(387,131)
Payments on license agreement, related party	(1,801,000)
Net Cash Used In Investing Activities	(2,188,131)
CASH FLOWS FROM FINANCING ACTIVITIES:
Loans payable	3,603,654	12,000
Loans from shareholders	1,368,049	9,736
Change in shareholders’ equity, net	(1,100,394)
Change in common stock	(40,158)
Net Cash Provided By Financing Activities	3,831,151	21,736
Net increase (decrease) in cash	28,761	(1,053)
Cash - Beginning of Year		1,053
Cash - End of Year	$ 28,761

Nature of Operations

Nature of Operations	12 Months Ended
	Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	Note 1 Nature of Operations Omnia Wellness Inc. ( the “Company”) was incorporated as a Nevada corporation on March 2, 2016 Nevada On June 25, 2019, Maksim Charniak, the Company’s then sole executive officer and director and the owner of 3,000,000 95.6 On March 5, 2020, the Company filed Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada to, among other things, (i) increase the Company’s authorized shares of common stock from 75,000,000 100,000,000 10,000,000 12.6374:1 On April 17, 2020, the Company entered into a Share Exchange and Reorganization Agreement (the “Exchange Agreement”) with Omnia Wellness Corporation (formerly known as Bed Therapies Inc.), a Texas corporation (“Omnia Corp.”), and the beneficial stockholders of Omnia Corp. to acquire 100 0.001 Accordingly, the Company acquired 100% of Omnia Corp. in exchange for the issuance of 10,000,000 (not adjusted to reflect the Company’s 15:1 forward stock split on April 6, 2021) shares of the Company’s common stock and Omnia Corp. became the Company’s wholly-owned subsidiary. As of the closing of the Acquisition (the “Closing”), Mr. Samad, resigned as an officer and director of the Company and agreed to cancel 52,656,888 1,269,665 539,000 As of immediately prior to the closing of the Acquisition, the Company entered into an Assignment and Assumption Agreement with RZI Consulting LLC (the “Assignment Agreement”), pursuant to which RZI Consulting LLC assumed substantially all of the Company’s remaining assets and liabilities through the closing of the Acquisition. Accordingly, as of the closing of the Acquisition, the Company had no assets or liabilities (other than relating to general and administrative expenses). Following the Acquisition, the Company, through its wholly-owned subsidiary Omnia Corp., now develops and markets products for wellness and physical therapy markets, using patented dry-hydro therapy equipment that the Company plans to offer and sell in medical and fitness markets. On April 6, 2021, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to (i) increase the Company’s authorized shares of common stock from 100,000,000 1,500,000,000 10,000,000 150,000,000 The Company’s principal executive office is located at 999 18 th In March 2020 the World Health Organization declared COVID-19 a pandemic. The Company is still assessing the impact COVID-19 may have on its business, but there can be no assurance that this analysis will enable the Company to avoid part or all of any impact from the spread of COVID-19 or its consequences, including downturns in business sentiment generally. The extent to which the COVID-19 pandemic and global efforts to contain its spread will impact the Company’s operations will depend on future developments, which are highly uncertain and cannot be predicted at this time, and include the duration, severity and scope of the pandemic and the actions taken to contain or treat the COVID-19 pandemic.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 Summary of Significant Accounting Policies The principal accounting policies applied in the preparation of these financial statements are set out below. Basis of Presentation Principles of Consolidation Accounting Estimates Risks and Uncertainties Loss Per Common Share 14,900,625 55,058,006 15 to 1 forward stock split 224,227,107 264,384,488 Cash Related Party Transactions Advance Payments on Purchases of Inventory, related party 16,000 0 Fixed Assets 108,746 0 Patent Cost 10 362,500 200,000 License Payable, related party Warranty Liability Beneficial Conversion Features Derivatives Revenue The Company derives its revenues primarily from the usage fees and sales of hydro therapy massage beds and installation services. Revenues from sales are recognized when the products are sold and delivered to its customers and the usage fees are earned based on subscription or actual usage. Sales Taxes and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue. Income Taxes The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary. Fair Value of Financial Instruments Fair Value Measurements and Disclosures ● Level 1: Quoted prices for identical assets and liabilities in active markets; ● Level 2: Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and ● Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts of financial instruments including cash, accounts payable, warrant liability and notes payable approximated fair value as of March 31, 2021 and 2020 due to the relatively short maturity of the respective instruments. Recently Issued Accounting Pronouncements – Leases (Topic 842) Leases (Topic 842): Targeted Improvements In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments

Going Concern

Going Concern	12 Months Ended
	Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 Going Concern The Company adopted Accounting Standards Update No. 2014-15, “Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”) The Company is commencing operations to generate sufficient revenue; however, the Company’s cash position may not be sufficient to support the Company’s daily operations. Management intends to raise additional funds by way of a private or public offering. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of private offering. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Related Parties

Related Parties	12 Months Ended
	Mar. 31, 2021
Related Party Transactions [Abstract]
Related Parties	Note 4 Related Parties The Company outsources its manufacturing pursuant to a Contract Services Agreement with DryRX, LLC dated as of January 1, 2020, which replaced and superseded the Contract Services Agreement with DryRX, LLC dated as of July 22, 2018 which expired in accordance with its terms. The Contract Services Agreement, among other things, provides that DryRX shall provide manufacturing and support services on behalf of the Company, and shall be responsible for the manufacturing oversight and production operations of the Company’s products. In return, the Company is obligated to pay to DryRX a fee equal to 10 The Company entered into a Consulting Agreement with Massagewave, Inc, owned and controlled by Steve Howe, to assist with business development and administrative activities. The agreement was entered into on May 1, 2018 and had required monthly payments of $ 15,000 April 30, 2020 25,985 0 1,500 0

Fixed Assets

Fixed Assets	12 Months Ended
	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Fixed Assets	Note 5 Fixed Assets The carrying basis and accumulated depreciation of fixed assets at March 31, 2021 and 2020 is as follows: Schedule of Fixed Assets Useful Lives March 31, 2021 March 31, 2020 Equipment in use 5 $ 99,000 $ - Equipment at 3 rd 5 212,000 - Building and Improvements 40 68,815 - Vehicles and trailers 5 60,266 - Less depreciation (125,704 ) Total fixed assets, net $ 314,377 - The Company recorded depreciation expense of $ 55,796 0

License Agreement, Related Part

License Agreement, Related Party	12 Months Ended
	Mar. 31, 2021
License Agreement Related Party
License Agreement, Related Party	Note 6 License Agreement, Related Party On April 30, 2019 the Company entered worldwide exclusive license with Drywave Technologies, Inc. (“Drywave”), a Company owned by Steve Howe. On the terms and conditions of the agreement, the Company received intellectual property rights to manufacture, use, and offer for sale all the products related to the patents and trademarks for dry hydrotherapy therapy technologies. The license fee to acquire the technology was $ 2,000,000 (a) $ 350,000 1,000 (b) $ 200,000 (c) $ 1,450,000 The Company made all the required payments as of March 31, 2021. After payment of the $ 2,000,000 The company recorded the original license fee as an intangible asset as of April 30, 2019 and is amortizing the asset over the expected useful life of the asset of 10 162,500 200,000

Notes Payable

Notes Payable	12 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Notes Payable	Note 7 Notes Payable The following are the various notes payable of the Company: PPP Loan - 294,066 1.0% 144,065.87 Promissory Notes were due May 2022 and June 2025 and the balance of $ 444,825 Nonconvertible notes, related party - 1,334,007 824,035 509,972 Schedule of Nonconvertible Notes Related Party Interest Rate Issuance Date Maturity 3/31/2021 4.00 % 12/31/2018 12/31/2020 55,250 4.00 % 12/31/2018 12/31/2020 66,900 4.00 % 12/31/2018 12/31/2020 74,220 4.00 % 9/30/2019 9/29/2021 314,000 4.00 % 9/17/2019 9/16/2020 81,500 4.00 % 9/30/2019 9/29/2021 12,450 1.00 % 12/31/2020 12/30/2022 254,382 1.00 % 12/31/2020 12/30/2022 235,600 1.00 % 12/31/2020 12/30/2022 99,970 1.00 % 12/31/2020 12/30/2022 83,785 4.00 % 12/31/2020 12/31/2021 53,100 4.00 % 12/31/2020 12/31/2021 2,850 1,334,007 Nonconvertible notes, non related- 1,919,620 1,745,000 174,620 Schedule of Nonconvertible Notes Non Related Interest Rate Default Rate Issuance Date Maturity 3/31/2021 14.00 % 8/1/18 1/31/20 500,000 14.00 % Additional 2 % 10/30/19 10/29/20 229,500 14.00 % N/A 2/5/2020 2/5/2021 51,000 20.00 % Additional 2 % 2/28/2020 8/27/2020 204,000 20.00 % Additional 2 % 2/25/2020 8/24/2020 208,000 20.00 % Additional 2 % 2/28/2020 8/27/2020 102,000 20.00 % Additional 2 % 4/14/2020 10/13/2020 102,000 14.00 % Additional 2 % 12/31/2019 12/31/2020 102,000 20.00 % Additional 2 % 4/24/2020 4/23/2021 20,000 20.00 % Additional 2 % 8/21/2020 8/20/2021 10,000 30.00 % Additional 2 % 10/29/2020 2/28/2021 25,500 - 12.00 % Additional 2 % 10/30/2020 11/1/2021 25,500 12.00 % Additional 2 % 10/30/2020 11/1/2021 25,500 2/5/2021 140,000 14.20 % 25.00 % 9/18/2019 9/18/2023 26,560 14.20 % 25.00 % 10/9/2019 10/9/2023 49,840 14.20 % 25.00 % 3/10/2020 3/10/2024 98,220 1,919,620 Convertible notes, related party 29,970 4 2 December 30, 2021 Maturity Date one the notes will bear interest at an annual rate of eight percent (8%). Convertible notes, non related 1,147,610 4% December 2020 Maturity Date one the notes will bear interest at an annual rate of eight percent (8%). December 2021 Upon commencement by the Company of an underwritten initial public offering (a “ Qualified IPO Common Stock Conversion Date Conversion Price SEC The notes payable outstanding balance is as follows: Schedule of Notes Payable Outstanding Balance March 31, 2021 March 31, 2020 PPP Loan 558,891 - Nonconvertible notes, related party 834,653 12,000 Nonconvertible notes, non related 1,745,000 Convertible notes, related party 29,970 6,546 Convertible notes, non related 1,107,143 Less: Non-current portion of PPP Loan (588,891 ) - No-current portion of nonconvertible notes-related party (509,972 ) - Non-current portion of nonconvertible notes, non related (174,620 ) - Current notes payable 3,002,174 18,546

Shareholders_ Equity (Deficit)

Shareholders’ Equity (Deficit)	12 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Shareholders’ Equity (Deficit)	Note 8 Shareholders’ Equity (Deficit) Common Stock - 1,500,000 0.001 a. One non-cumulative vote for each share held of record on all matters submitted to a vote of the stockholders; b. To participate equally and to receive any and all such dividends as may be declared by the Board of Directors out of funds legally available therefore; and c. To participate pro rata in any distribution of assets available for distribution upon liquidation. Stockholders have no pre-emptive rights to acquire additional shares of common stock or any other securities. Common shares are not subject to redemption and carry no subscription or conversion rights. Preferred Stock 10,000,000 150,000,000 No The Company has not declared or paid any dividends or returned any capital to common stock shareholders as of March 31, 2021 and 2020.

Income Taxes

Income Taxes	12 Months Ended
	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Note 9 Income Taxes Income Tax Expense For the fiscal year ended March 31, 2021, the reconciliation between the income tax benefit computed by applying the statutory U.S. federal income tax rate to the pre-tax loss before income taxes, and total income tax expense recognized in the financial statements is the change in the valuation allowance. For the fiscal year ended March 31, 2021 and 2020, the Company did not recognize any current income tax expense or benefit due to a full valuation allowance on its deferred income tax assets. Deferred Income Tax Assets As of March 31 , Summary of Significant Deferred Income Tax Assets and Liabilities March 31, 2021 March 31, 2020 Deferred income tax assets: Net operating loss carryforwards 475,902 Other - (5,359 ) Total deferred income tax assets - 470,543 Valuation allowance for deferred income tax assets - (470,543 ) Net deferred income tax assets - - For the fiscal years ended March 31, 2021 and 2020, the valuation allowance increased primarily as a result of the increase in net operating losses. In assessing the realizability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. NOL Carryforwards and Other Matters The Company files income tax returns in the U.S. federal jurisdiction and the state of Colorado. The Company’s federal and state tax years for the 2018 fiscal year and forward are subject to examination by taxing authorities. The Company did not have any unrecognized tax benefits as of March 31, 2021 and 2020. The Company’s policy is to account for any interest expense and penalties for unrecognized tax benefits as part of the income tax provision. The Company does not anticipate that unrecognized tax benefits will significantly increase or decrease within the next twelve months.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 10 Commitments and Contingencies Off-Balance Sheet Arrangements – Leases – 200 The Company leases a warehouse facility of approximately 1,500 2 2 Legal Matters During the periods ended March 31, 2021 and 2020, there are no proceedings in which the Company or any of our directors, officers or affiliates, or any registered or beneficial shareholders, is an adverse party or has a material interest adverse to our interest. Subsequent Events - 100,000,000 1,500,000,000 10,000,000 150,000,000 1:15 forward stock split of the common stock. During the year ended March 31, 2021, the Company entered into PPP loans under the Paycheck Protection Program sponsored by the U.S. Small Business Administration (SBA) providing for aggregate proceeds of $ 588,891 294,066 294,825 Effective as of July 14, 2021, the principal amount of the Company’s Senior Secured Promissory Note (the “Note”) with Auctus Fund, LLC (the “Lender”) was increased by $ 25,000

Restatement

Restatement	12 Months Ended
	Mar. 31, 2021
Restatement
Restatement	Note 11 Restatement The Company amended its Annual Report on Form 10-K for the fiscal year ended March 31, 2021 (the “Original Filing”), to restate its audited consolidated financial statements and related footnote disclosures to retroactively report an April 6, 2021, 15-1 forward stock split and delete the incorrect leases of inventory revenue disclosure statement for the period covered in the Original Filing. The Company currently does not hold any leases of inventory and has removed this disclosure from the footnotes of the financial statements in the Amendment No. 1 to the Original Filing, instead providing thatthe Company derives its revenues primarily from the usage fees and sales of hydro therapy massage beds and installation services. Revenues from sales are recognized when the products are sold and delivered to its customers and the usage fees are earned based on subscription or actual usage. Sales Taxes and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue. In addition, the weighted average earnings per share have been recalculated in the Consolidated Balance Sheets in the Amendment No. 1 to the Original Filing.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
Principles of Consolidation	Principles of Consolidation
Accounting Estimates	Accounting Estimates
Risks and Uncertainties	Risks and Uncertainties
Loss Per Common Share	Loss Per Common Share 14,900,625 55,058,006 15 to 1 forward stock split 224,227,107 264,384,488
Cash	Cash
Related Party Transactions	Related Party Transactions
Advance Payments on Purchases of Inventory, related party	Advance Payments on Purchases of Inventory, related party 16,000 0
Fixed Assets	Fixed Assets 108,746 0
Patent Cost	Patent Cost 10 362,500 200,000
License Payable, related party	License Payable, related party
Warranty Liability	Warranty Liability
Beneficial Conversion Features	Beneficial Conversion Features
Derivatives	Derivatives
Revenue	Revenue The Company derives its revenues primarily from the usage fees and sales of hydro therapy massage beds and installation services. Revenues from sales are recognized when the products are sold and delivered to its customers and the usage fees are earned based on subscription or actual usage. Sales Taxes and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue.
Income Taxes	Income Taxes The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value Measurements and Disclosures ● Level 1: Quoted prices for identical assets and liabilities in active markets; ● Level 2: Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and ● Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts of financial instruments including cash, accounts payable, warrant liability and notes payable approximated fair value as of March 31, 2021 and 2020 due to the relatively short maturity of the respective instruments.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements – Leases (Topic 842) Leases (Topic 842): Targeted Improvements In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments

Fixed Assets (Tables)

Fixed Assets (Tables)	12 Months Ended
	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	The carrying basis and accumulated depreciation of fixed assets at March 31, 2021 and 2020 is as follows: Schedule of Fixed Assets Useful Lives March 31, 2021 March 31, 2020 Equipment in use 5 $ 99,000 $ - Equipment at 3 rd 5 212,000 - Building and Improvements 40 68,815 - Vehicles and trailers 5 60,266 - Less depreciation (125,704 ) Total fixed assets, net $ 314,377 -

Notes Payable (Tables)

Notes Payable (Tables)	12 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Schedule of Nonconvertible Notes Related Party	Schedule of Nonconvertible Notes Related Party Interest Rate Issuance Date Maturity 3/31/2021 4.00 % 12/31/2018 12/31/2020 55,250 4.00 % 12/31/2018 12/31/2020 66,900 4.00 % 12/31/2018 12/31/2020 74,220 4.00 % 9/30/2019 9/29/2021 314,000 4.00 % 9/17/2019 9/16/2020 81,500 4.00 % 9/30/2019 9/29/2021 12,450 1.00 % 12/31/2020 12/30/2022 254,382 1.00 % 12/31/2020 12/30/2022 235,600 1.00 % 12/31/2020 12/30/2022 99,970 1.00 % 12/31/2020 12/30/2022 83,785 4.00 % 12/31/2020 12/31/2021 53,100 4.00 % 12/31/2020 12/31/2021 2,850 1,334,007
Schedule of Nonconvertible Notes Non Related	Schedule of Nonconvertible Notes Non Related Interest Rate Default Rate Issuance Date Maturity 3/31/2021 14.00 % 8/1/18 1/31/20 500,000 14.00 % Additional 2 % 10/30/19 10/29/20 229,500 14.00 % N/A 2/5/2020 2/5/2021 51,000 20.00 % Additional 2 % 2/28/2020 8/27/2020 204,000 20.00 % Additional 2 % 2/25/2020 8/24/2020 208,000 20.00 % Additional 2 % 2/28/2020 8/27/2020 102,000 20.00 % Additional 2 % 4/14/2020 10/13/2020 102,000 14.00 % Additional 2 % 12/31/2019 12/31/2020 102,000 20.00 % Additional 2 % 4/24/2020 4/23/2021 20,000 20.00 % Additional 2 % 8/21/2020 8/20/2021 10,000 30.00 % Additional 2 % 10/29/2020 2/28/2021 25,500 - 12.00 % Additional 2 % 10/30/2020 11/1/2021 25,500 12.00 % Additional 2 % 10/30/2020 11/1/2021 25,500 2/5/2021 140,000 14.20 % 25.00 % 9/18/2019 9/18/2023 26,560 14.20 % 25.00 % 10/9/2019 10/9/2023 49,840 14.20 % 25.00 % 3/10/2020 3/10/2024 98,220 1,919,620
Schedule of Notes Payable Outstanding Balance	The notes payable outstanding balance is as follows: Schedule of Notes Payable Outstanding Balance March 31, 2021 March 31, 2020 PPP Loan 558,891 - Nonconvertible notes, related party 834,653 12,000 Nonconvertible notes, non related 1,745,000 Convertible notes, related party 29,970 6,546 Convertible notes, non related 1,107,143 Less: Non-current portion of PPP Loan (588,891 ) - No-current portion of nonconvertible notes-related party (509,972 ) - Non-current portion of nonconvertible notes, non related (174,620 ) - Current notes payable 3,002,174 18,546

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Summary of Significant Deferred Income Tax Assets and Liabilities	As of March 31 , Summary of Significant Deferred Income Tax Assets and Liabilities March 31, 2021 March 31, 2020 Deferred income tax assets: Net operating loss carryforwards 475,902 Other - (5,359 ) Total deferred income tax assets - 470,543 Valuation allowance for deferred income tax assets - (470,543 ) Net deferred income tax assets - -

Nature of Operations (Details N

Nature of Operations (Details Narrative) - USD ($)	Apr. 06, 2021	Jan. 05, 2021	Apr. 17, 2020	Mar. 05, 2020	Jun. 25, 2019	Mar. 31, 2021	Mar. 31, 2020	Mar. 04, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Entity incorporation, date of incorporation						Mar. 2, 2016
Entity incorporation, state or country code						NV
Equity method investment description						On June 25, 2019, Maksim Charniak, the Company’s then sole executive officer and director and the owner of 3,000,000 shares (pre-stock split) of the Company’s common stock, sold all of his shares of common stock of the Company to Amer Samad, resulting in a change of control of the Company. As part of that transaction, Mr. Charniak resigned from all of his officer and director positions, and Mr. Samad was appointed as the Chief Executive Officer, President, Chief Financial Officer and Secretary of the Company, and was appointed to the Board of Directors of the Company. Mr. Samad also purchased 1,167,937 shares (pre-stock split) of the Company’s common stock in a series of private transactions, resulting in Mr. Samad owning 4,167,937 shares (pre-stock split) of the Company’s common stock, or approximately 95.6% of the issued and outstanding common stock of the Company.
Common stock, shares authorized				100,000,000		1,500,000,000	1,500,000,000	75,000,000
Preferred stock authorized						150,000,000	150,000,000
Stockholders equity description				12.6374:1		15 to 1 forward stock split
Common stock, par value						$ 0.001	$ 0.001
Minimum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock, shares authorized	100,000,000
Preferred stock authorized	10,000,000
Maximum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock, shares authorized	1,500,000,000
Preferred stock authorized	150,000,000
Exchange Agreement [Member] | Bed Therapies Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period shares stock splits		1,269,665
Ownership percentage			100.00%
Stockholders equity description			Accordingly, the Company acquired 100% of Omnia Corp. in exchange for the issuance of 10,000,000 (not adjusted to reflect the Company’s 15:1 forward stock split on April 6, 2021) shares of the Company’s common stock and Omnia Corp. became the Company’s wholly-owned subsidiary. As of the closing of the Acquisition (the “Closing”), Mr. Samad, resigned as an officer and director of the Company and agreed to cancel 52,656,888
Common stock, par value			$ 0.001
Debt principal amount			$ 539,000
Blank Check [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Preferred stock authorized				10,000,000
Mr Amer Samad [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period shares stock splits					3,000,000
Ownership percentage					95.60%
Mr Amer Samad [Member] | Exchange Agreement [Member] | Bed Therapies Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stockholders equity description	Company filed a Certificate of Change with the Secretary of State of the State of Nevada to (i) increase the Company’s authorized shares of common stock from 100,000,000 to 1,500,000,000, (ii) increase the Company’s authorized shares of “blank check” preferred stock from 10,000,000 to 150,000,000, and (iii) effect a 1:15 forward stock split of the common stock.
Cancellation of stock split			52,656,888

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Mar. 05, 2020	Apr. 30, 2019	Mar. 31, 2021	Mar. 31, 2020
Short-term Debt [Line Items]
Number of anti-dilutive common stock			14,900,625	55,058,006
Stock split description	12.6374:1		15 to 1 forward stock split
Advances on inventory			$ 16,000	$ 0
Accumulated depreciation			$ 108,746	0
Intangible asset expected life		10 years	10 years
Accumulated amortization			$ 362,500	$ 200,000
Income tax, descripition			The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.
Convertible Notes Payable [Member]
Short-term Debt [Line Items]
Number of anti-dilutive common stock			224,227,107	264,384,488

Related Parties (Details Narrat

Related Parties (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Related Party Transaction [Line Items]
Payments of related party	$ 1,100,394
Consulting expense, related party	25,985	$ 0
Accounts payable, related party	$ 1,500	$ 0
Contract Services Agreement [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Rate	10.00%
Consulting Agreement [Member]
Related Party Transaction [Line Items]
Related party transaction, description	The Company entered into a Consulting Agreement with Massagewave, Inc, owned and controlled by Steve Howe, to assist with business development and administrative activities. The agreement was entered into on May 1, 2018 and had required monthly payments of $15,000 per month. The agreement expired on April 30, 2020 with renewal options. The Company incurred consulting expense, related party of $25,985 and $-0- as of March 31, 2021 and 2020, respectively. The Company also has an accounts payable, related party balance of $1,500 and $-0- as of March 31, 2021 and 2020, respectively. The due to and due from accounts are to various investors and related parties above for business related activities.
Agreement expires date	Apr. 30, 2020
Consulting Agreement [Member] | Massagewave Inc [Member]
Related Party Transaction [Line Items]
Payments of related party	$ 15,000

Schedule of Fixed Assets (Detai

Schedule of Fixed Assets (Details) - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Property, Plant and Equipment [Line Items]
Less depreciation	$ (125,704)
Total fixed assets, net	$ 314,377
Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Fixed assets, gross	$ 99,000
Equipment Third Party Locations [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Fixed assets, gross	$ 212,000
Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Useful lives	40 years
Fixed assets, gross	$ 68,815
Vehicles And Trailers [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Fixed assets, gross	$ 60,266

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation	$ 55,796	$ 0

License Agreement, Related Pa_2

License Agreement, Related Party (Details Narrative) - USD ($)	Mar. 02, 2020	Oct. 30, 2019	Apr. 30, 2019	Mar. 31, 2021	Mar. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Payment to acquire technology	$ 1,450,000	$ 200,000	$ 350,000	$ 1,801,000
Payment of escrow fee			$ 1,000
Intangible asset expected life			10 years	10 years
Amortization expense				$ 162,500	$ 200,000
Drywave Technologies Inc [Member] | License Agreement [Member]
Defined Benefit Plan Disclosure [Line Items]
Payable on license fee acquired			$ 2,000,000
Related party description				After payment of the $2,000,000 License Fee and not later than April 30, 2020, the Company will pay to Drywave a royalty of 3% of Net Sales beginning May 1, 2020 and continuing for the longer of the period in which there are valid patent claims or ten years. The Company is performing on this agreement.

Schedule of Nonconvertible Note

Schedule of Nonconvertible Notes Related Party (Details)	12 Months Ended
	Mar. 31, 2021USD ($)
Nonconvertible Notes, Related Party One [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 55,250
Nonconvertible Notes, Related Party Two [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 66,900
Nonconvertible Notes, Related Party Three [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 74,220
Nonconvertible Notes, Related Party Four [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Sep. 30, 2019
Maturity	Sep. 29, 2021
Unsecured Notes Payable	$ 314,000
Nonconvertible Notes, Related Party Five [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Sep. 17, 2019
Maturity	Sep. 16, 2020
Unsecured Notes Payable	$ 81,500
Nonconvertible Notes, Related Party Six [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Sep. 30, 2019
Maturity	Sep. 29, 2021
Unsecured Notes Payable	$ 12,450
Nonconvertible Notes, Related Party Seven [Member]
Short-term Debt [Line Items]
Interest Rate	1.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Notes Payable	$ 254,382
Nonconvertible Notes, Related Party Eight [Member]
Short-term Debt [Line Items]
Interest Rate	1.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Notes Payable	$ 235,600
Nonconvertible Notes, Related Party Nine [Member]
Short-term Debt [Line Items]
Interest Rate	1.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Notes Payable	$ 99,970
Nonconvertible Notes, Related Party Ten [Member]
Short-term Debt [Line Items]
Interest Rate	1.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Notes Payable	$ 83,785
Nonconvertible Notes, Related Party Eleven [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 31, 2021
Unsecured Notes Payable	$ 53,100
Nonconvertible Notes, Related Party Twelve [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 31, 2021
Unsecured Notes Payable	$ 2,850
Nonconvertible Notes Related Party [Member]
Short-term Debt [Line Items]
Unsecured Notes Payable	$ 1,334,007

Schedule of Nonconvertible No_2

Schedule of Nonconvertible Notes Non Related (Details)	12 Months Ended
	Mar. 31, 2021USD ($)
Nonconvertible Notes, Non Related One [Member]
Short-term Debt [Line Items]
Interest Rate	14.00%
Issuance Date	Aug. 1, 2018
Maturity	Jan. 31, 2020
Unsecured Notes Payable	$ 500,000
Nonconvertible Notes, Non Related Two [Member]
Short-term Debt [Line Items]
Interest Rate	14.00%
Issuance Date	Oct. 30, 2019
Maturity	Oct. 29, 2020
Unsecured Notes Payable	$ 229,500
Default Rate	Additional 2
Nonconvertible Notes, Non Related Three [Member]
Short-term Debt [Line Items]
Interest Rate	14.00%
Issuance Date	Feb. 5, 2020
Maturity	Feb. 5, 2021
Unsecured Notes Payable	$ 51,000
Default Rate	N/A
Nonconvertible Notes, Non Related Four [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Feb. 28, 2020
Maturity	Aug. 27, 2020
Unsecured Notes Payable	$ 204,000
Default Rate	Additional 2
Nonconvertible Notes, Non Related Five [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Feb. 25, 2020
Maturity	Aug. 24, 2020
Unsecured Notes Payable	$ 208,000
Default Rate	Additional 2
Nonconvertible Notes, Non Related Six [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Feb. 28, 2020
Maturity	Aug. 27, 2020
Unsecured Notes Payable	$ 102,000
Default Rate	Additional 2
Nonconvertible Notes, Non Related Seven [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Apr. 14, 2020
Maturity	Oct. 13, 2020
Unsecured Notes Payable	$ 102,000
Default Rate	Additional 2
Nonconvertible Notes, Non Related Eight [Member]
Short-term Debt [Line Items]
Interest Rate	14.00%
Issuance Date	Dec. 31, 2019
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 102,000
Default Rate	Additional 2
Nonconvertible Notes, Non Related Nine [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Apr. 24, 2020
Maturity	Apr. 23, 2021
Unsecured Notes Payable	$ 20,000
Default Rate	Additional 2
Nonconvertible Notes, Non Related Ten [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Aug. 21, 2020
Maturity	Aug. 20, 2021
Unsecured Notes Payable	$ 10,000
Default Rate	Additional 2
Nonconvertible Notes, Non Related Eleven [Member]
Short-term Debt [Line Items]
Interest Rate	30.00%
Issuance Date	Oct. 29, 2020
Maturity	Feb. 28, 2021
Unsecured Notes Payable	$ 25,500
Default Rate	Additional 2
Nonconvertible Notes, Non Related Twelve [Member]
Short-term Debt [Line Items]
Interest Rate	12.00%
Issuance Date	Oct. 30, 2020
Maturity	Nov. 1, 2021
Unsecured Notes Payable	$ 25,500
Default Rate	Additional 2
Nonconvertible Notes, Non Related Thirteen [Member]
Short-term Debt [Line Items]
Interest Rate	12.00%
Issuance Date	Oct. 30, 2020
Maturity	Nov. 1, 2021
Unsecured Notes Payable	$ 25,500
Default Rate	Additional 2
Nonconvertible Notes, Non Related Fourteen [Member]
Short-term Debt [Line Items]
Issuance Date	Feb. 5, 2021
Unsecured Notes Payable	$ 140,000
Nonconvertible Notes, Non Related Fifteen [Member]
Short-term Debt [Line Items]
Interest Rate	14.20%
Issuance Date	Sep. 18, 2019
Maturity	Sep. 18, 2023
Unsecured Notes Payable	$ 26,560
Default Rate	25.00
Nonconvertible Notes, Non Related Sixteen [Member]
Short-term Debt [Line Items]
Interest Rate	14.20%
Issuance Date	Oct. 9, 2019
Maturity	Oct. 9, 2023
Unsecured Notes Payable	$ 49,840
Default Rate	25.00
Nonconvertible Notes, Non Related Seventeen [Member]
Short-term Debt [Line Items]
Interest Rate	14.20%
Issuance Date	Mar. 10, 2020
Maturity	Mar. 10, 2024
Unsecured Notes Payable	$ 98,220
Default Rate	25.00
Nonconvertible Notes, Non Related [Member]
Short-term Debt [Line Items]
Unsecured Notes Payable	$ 1,919,620

Schedule of Notes Payable Outst

Schedule of Notes Payable Outstanding Balance (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Short-term Debt [Line Items]
Current notes payable	$ 3,002,174	$ 18,546
PPP Loan [Member]
Short-term Debt [Line Items]
Notes payable	558,891
Non-current notes payable	(588,891)
Nonconvertible Notes Related Party [Member]
Short-term Debt [Line Items]
Notes payable	834,653	12,000
Non-current notes payable	(509,972)
Nonconvertible Notes, Non Related [Member]
Short-term Debt [Line Items]
Notes payable	1,745,000
Non-current notes payable	(174,620)
Convertible Notes, Related Party [Member]
Short-term Debt [Line Items]
Notes payable	29,970	$ 6,546
Convertible Notes, Non Related [Member]
Short-term Debt [Line Items]
Notes payable	$ 1,107,143

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	May 12, 2021	Mar. 31, 2021
Nonconvertible Notes Related Party [Member]
Short-term Debt [Line Items]
Unsecured notes payable		$ 1,334,007
Nonconvertible Notes Related Party [Member] | Investor [Member]
Short-term Debt [Line Items]
Unsecured notes payable		1,334,007
Short term unsecured notes payable		824,035
Long term unsecured notes payable		509,972
Nonconvertible Notes, Non Related [Member]
Short-term Debt [Line Items]
Unsecured notes payable		1,919,620
Nonconvertible Notes, Non Related [Member] | Investor [Member]
Short-term Debt [Line Items]
Unsecured notes payable		1,919,620
Short term unsecured notes payable		1,745,000
Long term unsecured notes payable		$ 174,620
Convertible Notes, Related Party [Member] | Investor [Member]
Short-term Debt [Line Items]
Debt instrument, interest rate		4.00%
Unsecured notes payable		$ 29,970
Debt instrument, default interest rate		2.00%
Debt instrument, maturity date		Dec. 30, 2021
Debt instrument term		1 year
Debt instrument, interest rate terms		the notes will bear interest at an annual rate of eight percent (8%).
Convertible Notes, Non Related [Member] | Investor [Member]
Short-term Debt [Line Items]
Debt instrument, interest rate		4.00%
Unsecured notes payable		$ 1,147,610
Debt instrument, maturity date		Dec. 31, 2020
Debt instrument term		1 year
Debt instrument, interest rate terms		the notes will bear interest at an annual rate of eight percent (8%).
Convertible Notes, Non Related [Member] | Investor [Member] | Extended Maturity [Member]
Short-term Debt [Line Items]
Debt instrument, maturity date		Dec. 31, 2021
CARES Act [Member] | Paycheck Protection Program Loan [Member]
Short-term Debt [Line Items]
Proceeds from loan		$ 294,066
Debt instrument, interest rate		1.00%
Debt instrument, forgiveness	$ 144,065.87	$ 444,825
Debt instrument, description		Promissory Notes were due May 2022 and June 2025 and the balance of $444,825 may be forgiven subject to the terms of the Paycheck Protection Program.

Shareholders_ Equity (Deficit)

Shareholders’ Equity (Deficit) (Details Narrative) - $ / shares	Apr. 06, 2021	Mar. 31, 2021	Mar. 31, 2020	Mar. 05, 2020	Mar. 04, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized		1,500,000,000	1,500,000,000	100,000,000	75,000,000
Common stock par value		$ 0.001	$ 0.001
Preferred stock, shares authorized		150,000,000	150,000,000
Preferred stock, shares outstanding		0	0
Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized	100,000,000
Preferred stock, shares authorized	10,000,000
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized	1,500,000,000
Preferred stock, shares authorized	150,000,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized		1,500,000

Summary of Significant Deferred

Summary of Significant Deferred Income Tax Assets and Liabilities (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Net operating loss carryforwards		$ 475,902
Other		(5,359)
Total deferred income tax assets		470,543
Valuation allowance for deferred income tax assets		(470,543)
Net deferred income tax assets

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	Apr. 06, 2021shares	Mar. 31, 2021USD ($)ft²shares	Jul. 14, 2021USD ($)	Mar. 31, 2020shares	Mar. 05, 2020shares	Mar. 04, 2020shares
Loss Contingencies [Line Items]
Area of land | ft²		200
Common stock, shares authorized		1,500,000,000		1,500,000,000	100,000,000	75,000,000
Preferred stock, shares authorized		150,000,000		150,000,000
Stock split	1:15 forward stock split of the common stock.
PPP Loans [Member]
Loss Contingencies [Line Items]
Aggregate proceeds from loan | $		$ 588,891
First PPP Loans [Member] | May 12, 2021 [Member]
Loss Contingencies [Line Items]
Debt forgiven | $		294,066
Second PPP Loans [Member] | In 2021 [Member]
Loss Contingencies [Line Items]
Debt forgiven | $		$ 294,825
Senior Secured Promissory Note [Member] | Auctus Fund, LLC [Member]
Loss Contingencies [Line Items]
Debt, increase in principal amount | $			$ 25,000
Minimum [Member]
Loss Contingencies [Line Items]
Common stock, shares authorized	100,000,000
Preferred stock, shares authorized	10,000,000
Maximum [Member]
Loss Contingencies [Line Items]
Common stock, shares authorized	1,500,000,000
Preferred stock, shares authorized	150,000,000
Master Facility License Agreement [Member]
Loss Contingencies [Line Items]
Area of land | ft²		1,500
Gross revenue percentage		2.00%
Lease expiration period		2 years